{"id":"NCT01936181","sponsor":"Samsung Bioepis Co., Ltd.","briefTitle":"A Study Comparing SB2 to Remicade® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy","officialTitle":"A Randomised, Double-blind, Parallel Group, Multicentre Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity of SB2 Compared to Remicade® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-08","primaryCompletion":"2014-09","completion":"2015-09","firstPosted":"2013-09-05","resultsPosted":"2016-08-29","lastUpdate":"2017-09-14"},"enrollment":584,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"DRUG","name":"Remicade (infliximab)","otherNames":[]},{"type":"DRUG","name":"SB2 (proposed biosimilar to infliximab)","otherNames":[]}],"arms":[{"label":"SB2 (proposed biosimilar to inflixmab)","type":"EXPERIMENTAL"},{"label":"Remicade (infliximab)","type":"ACTIVE_COMPARATOR"},{"label":"Remicade (infliximab), switch to SB2","type":"EXPERIMENTAL"},{"label":"Remicade (infliximab), continue as Remicade","type":"ACTIVE_COMPARATOR"}],"summary":"This is a randomized, double-blind, parallel group, multicentre clinical study to evaluate the efficacy, safety, pharmacokinetics and immunogenicity of SB2 compared to Remicade in subjects with moderate to severe Rheumatoid Arthritis (RA) despite Methotrexate (MTX) therapy.","primaryOutcome":{"measure":"American College of Rheumatology 20% Response Criteria (ACR20)","timeFrame":"Week 30","effectByArm":[{"arm":"SB2 (Proposed Biosimilar to Inflixmab)","deltaMin":64.1,"sd":null},{"arm":"Remicade (Infliximab)","deltaMin":66,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":2,"countries":["Bulgaria","Lithuania"]},"refs":{"pmids":["31958281","29042358","28957563","26318384"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":36,"n":290},"commonTop":["Nasopharyngitis","Latent Tuberculosis","Alanine Aminotransferase Increased","Rheumatoid Arthritis","Upper Respiratory Tract Infection"]}}